# FDA Inspection 1025638 - Purdue Pharma - August 04, 2017

Source: https://www.keypedia.com/records/fda_inspections/purdue-pharma/c09a565e-99e1-4ef2-b5b5-77c6ebd5773d
Source feed: FDA_Inspections

> FDA Inspection 1025638 for Purdue Pharma on August 04, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1025638
- Company Name: Purdue Pharma
- Inspection Date: 2017-08-04
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1087591 - 2019-04-26](https://www.keypedia.com/records/fda_inspections/purdue-pharma/e8217f26-6c57-472f-82cb-55f276da838b)
- [FDA Inspection 938743 - 2015-07-10](https://www.keypedia.com/records/fda_inspections/purdue-pharma/7e158fb3-874a-431c-babb-6b6d8662d23c)
- [FDA Inspection 852516 - 2013-09-13](https://www.keypedia.com/records/fda_inspections/purdue-pharma/2cd4bbf9-a993-4692-aa87-b42d35c7bb54)
- [FDA Inspection 734736 - 2011-07-15](https://www.keypedia.com/records/fda_inspections/purdue-pharma/bc3ea2f8-59b1-4c6d-bf86-58404943497a)

Company: https://www.keypedia.com/companies/purdue-pharma/9f005c9c-c52f-4830-b544-bd991a18cc7c

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c